High frequency of prostate antigen-directed T cells in cancer patients compared to healthy age-matched individuals-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High frequency of prostate antigen-directed T cells in cancer patients compared to healthy age-matched individuals

Published:2008-09-22 Issue:1 Volume:69 Page:70-81
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Forsberg Ole,Carlsson Björn,Malmström Per-Uno,Ullenhag Gustav,Tötterman Thomas H.,Essand Magnus

Funder

Swedish Cancer Society

Gunnar Nilsson's Cancer Foundation

Lion's Cancer Foundation in Uppsala

Publisher

Wiley

Subject

Urology,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pros.20858/fullpdf

Reference59 articles.

1. Cancer statistics, 2006;Jemal;CA Cancer J Clin,2006

2. Progress in human tumour immunology and immunotherapy;Rosenberg;Nature,2001

3. A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer;Pavlenko;Br J Cancer,2004

4. Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen;Murphy;Prostate,1996

5. Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides;Tjoa;Prostate,1998

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer Vaccines in the Immunotherapy Era: Promise and Potential;Vaccines;2023-11-29

2. Malignancy in common variable immunodeficiency: a systematic review and meta-analysis;Expert Review of Clinical Immunology;2019-09-15

3. Impact of curative radiotherapy on the immune status of patients with localized prostate cancer;OncoImmunology;2018-08-27

4. Systemic treatment with CAR-engineered T cells against PSCA delays subcutaneous tumor growth and prolongs survival of mice;BMC Cancer;2014-01-18

5. DNA vaccine coding for the rhesus prostate specific antigen delivered by intradermal electroporation in patients with relapsed prostate cancer;Vaccine;2013-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3